Shanghai RAAS Blood Products Co., Ltd.
002252
Rangering i aksjer
#3656
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aksjekurs
$0.72625991
Markedsverdi
$4.79B
Endring (1 dag)
2.70%
Endring (1 år)
-22.68%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
P/B-forhold for Shanghai RAAS Blood Products Co., Ltd. (002252)
P/B-forhold per October 2026 TTM: 1.01
Ifølge Shanghai RAAS Blood Products Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 1.01. Ved slutten av 2023 hadde selskapet et P/B-forhold på 1.70.
P/B-historikk for Shanghai RAAS Blood Products Co., Ltd. fra 2005 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 1.01 | -32.79% |
| 2024 | 1.50 | -11.55% |
| 2023 | 1.70 | 14.59% |
| 2022 | 1.48 | -16.45% |
| 2021 | 1.77 | -10.61% |
| 2020 | 1.99 | -39.37% |
| 2019 | 3.27 | -8.41% |
| 2018 | 3.58 | -54.12% |
| 2017 | 7.79 | -19.17% |
| 2016 | 9.64 | -6.16% |
| 2015 | 10.27 | 68.88% |
| 2014 | 6.08 | -86.55% |
| 2013 | 45.24 | 241.08% |
| 2012 | 13.26 | -5.97% |
| 2011 | 14.11 | -38.54% |
| 2010 | 22.95 | 46.93% |
| 2009 | 15.62 | 66.48% |
| 2008 | 9.38 | -68.34% |
| 2007 | 29.64 | 158.32% |
| 2006 | 11.47 | 47.63% |
| 2005 | 7.77 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 6.251 | 520.02% |
US
|
|
| 13.2547 | 1,214.69% |
US
|
|
| 4.208 | 317.38% |
AU
|
|
| 6.1824 | 513.21% |
NL
|
|
| - | - |
CH
|
